Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis is well-positioned to see strong growth in the coming years, with the introduction of its next-generation robotic magnetic navigation system, Genesis. This new system has the potential to tap into a previously inaccessible customer base and generate significant revenue, while also driving a replacement cycle for its existing core Niobe technology platform and its associated recurring revenue streams. Additionally, the recent acquisition of Robocath and its commercial PCI system provides another potential source of revenue, and we expect the company to continue to make progress in this area. Despite a temporary delay in system sales, Stereotaxis remains on track for long-term success and is a strong investment opportunity.

Stereotaxis is facing several potential risks, such as slow adoption of new technologies by healthcare providers, collaboration risk with other manufacturers and producers, and long and variable sales and installation cycles. The recent Q1 financial results were below expectations, with lower recurring and systems revenue and higher operating expenses. Despite potential headwinds, management remains optimistic about the potential for growth with a revamped product portfolio and expect revenues to exceed $40M for FY26, driven by the ramp-up in MAGiC catheter manufacturing and 5 expected GenesisX placements by the end of the year.